| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $184.9M | +42.2% |
| SG&A Expense | $49.9M | +33.0% |
| Operating Income | -$223.1M | -34.7% |
| Pre-tax Income | -$199.8M | -27.0% |
| Income Tax | $275K | +418.9% |
| Net Income | -$200.1M | -27.1% |
| EPS (Basic) | -$3.12 | -7.2% |
| EPS (Diluted) | -$3.12 | -7.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $206.2M | +78.6% |
| Short-term Investments | $417.8M | -4.9% |
| Current Assets | $637.9M | +13.3% |
| Total Assets | $752.7M | +10.8% |
| Current Liabilities | $37.0M | +5.4% |
| Total Liabilities | $153.2M | +19.4% |
| Stockholders' Equity | $599.5M | +8.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$149.5M | -22.2% |
| Capital Expenditures | $9.3M | -29.8% |
| Investing Cash Flow | $27.7M | +117.8% |
| Financing Cash Flow | $212.6M | -35.4% |
| Free Cash Flow | -$158.8M | -17.2% |